OR WAIT null SECS
October 24, 2023
The report indicates a rise in biotech funding and subsequent growth for pharma contract services.
The final guidance document was issued to assist bio/pharma companies in the clinical development and licensure of COVID-19 vaccines.
Bettersize US showcases their BeNano Series, Bettersizer 2600, and BetterPyc 380 instruments at the AAPS 2023 PharmSci 360 event.
October 20, 2023
Waters has launched OligoWorks SPE Workflow and Kits, which is aimed at accelerating the bioanalysis of oligonucleotides.
The designation will grant Lisata EU marketing exclusivity for 10 years after approval and protocol assistance from EMA.
The spinal muscular atrophy treatment, currently marketed by Roche, generated $1.2 billion in sales in 2022.
October 18, 2023
SCHOTT now offers ViewCell, a new component meant to add flexibility to biopharmaceutical process control.
These results will provide insights from more than 250 global pharma executives, including discoveries such as pharma confidence dipping below the record scores of 2022, although it has remained extremely resilient despite wider macro uncertainly, according to the press release.
Spark Therapeutics and SpliceBio have formed a collaboration to develop a gene therapy that can treat an inherited retinal disease.
The agency is warning patients and healthcare providers about pre-filled pens falsely labeled as Ozempic.